
Innogest Capital
Description
Innogest Capital, officially known as Innogest SGR S.p.A., is a prominent Italian venture capital firm with a strong focus on seed and early-stage investments across Italy and Europe. Headquartered in Turin, the firm has established itself as a key player in the European startup ecosystem by backing innovative companies with high growth potential. Innogest SGR operates through two specialized funds, each targeting distinct sectors to maximize expertise and impact.
The firm's investment strategy is bifurcated into two main areas. The "Innogest Capital" fund is dedicated to digital startups, typically deploying initial cheques ranging from €200,000 to €2 million. This fund targets companies leveraging technology to disrupt various industries, from software and e-commerce to fintech and AI. Concurrently, the "Innogest Investments" fund focuses on the MedTech sector, providing capital to healthcare technology ventures. For MedTech companies, the typical first investment size ranges from €500,000 to €3 million, reflecting the often higher capital requirements for development and regulatory processes in this field.
Innogest SGR is known for its hands-on approach, providing not just capital but also strategic guidance, industry connections, and operational support to its portfolio companies. With a portfolio exceeding 60 investments and a track record of 10 successful exits, the firm demonstrates a commitment to fostering long-term growth and achieving significant returns. Its dual-fund structure allows for specialized expertise and tailored support, making it a valuable partner for founders navigating the complexities of their respective markets.
Investor Profile
Innogest Capital has backed more than 68 startups, with 1 new investments in the last 12 months alone. The firm has led 25 rounds, about 37% of its total and boasts 11 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Seed, Series A rounds (top funding stages).
- Majority of deals are located in Italy, United States, Spain.
- Strong thematic focus on Health Care, Biotechnology, Medical Device.
- Typical check size: $216K – $3.2M.
Stage Focus
- Series Unknown (28%)
- Seed (24%)
- Series A (22%)
- Series B (18%)
- Series C (6%)
- Post Ipo Equity (3%)
Country Focus
- Italy (75%)
- United States (9%)
- Spain (9%)
- Switzerland (3%)
- United Kingdom (3%)
- Israel (1%)
Industry Focus
- Health Care
- Biotechnology
- Medical Device
- E-commerce
- Medical
- Hospital
- Fashion
- Mobile
- Recycling
- Sustainability
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.